We report a case of 46-year-old white female with a history of systemic lupus erythematosus (SLE), diagnosed 19 years prior, who had previously been hospitalized for lupus myocarditis and class IV lupus nephritis. She was currently under treatment with hydroxychloroquine and prednisone. She reported sporadic arthralgia, with relief after analgesic use. She reported no history of infectious diseases. Transthoracic echocardiography revealed normal systolic and diastolic function, with mild aortic, tricuspid, mitral, and pulmonary valve regurgitation. Laboratory tests showed positivity for anti-double stranded DNA antibody and anti-single stranded DNA antibody, with a decreased CH50 (7 U/mL; reference range: 23.0-46.0 U/mL), C3 (47 mg/L; reference range: 90-180 mg/L), and C4 (< 6 mg/L; reference range: 10-40 mg/L). Urinalysis showed normal urinary creatinine (624 mg/24 h; reference range: 0.6-1.6 g/24 h) and elevated urinary protein (232 mg/24 h; reference range: < 150 mg/24 h). During the follow-up of the patient, an abdominal ultrasound was requested, and, during the examination, the spleen could not be visualized, although no other abnormalities. To rule out SLE-related systemic abnormalities, whole-body computed tomography was performed. The examination showed decreased spleen size, accompanied by small, diffuse, predominantly subcapsular and peripheral, nodular calcifications, some of which were confluent, with relative sparing of the central regions (Figure 1).